Inhibitory effects of spinorphin, a novel endogenous regulator, on chemotaxis, O2- generation, and exocytosis by N-formylmethionyl-leucyl-phenylalanine (FMLP)-stimulated neutrophils

Biochemical Pharmacology

Volumn 54, Issue 6, 1997, Pages 695-701

  Yamamoto, Yukio ^a   Kanazawa, Tadahiro ^a   Shimamura, Mariko ^a   Oeki, Masaaki ^b   Hazato, Tadahiko ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Chemotaxis; Exocytosis; FMLP receptor; Heptapeptide; Neutrophil; O2 generation

Indexed keywords

ANGIOTENSIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HEPTAPEPTIDE; OXYGEN RADICAL; PHOSPHORAMIDON; SPINORPHIN; SUBSTANCE P; SUPEROXIDE;

ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; EXOCYTOSIS; HUMAN; HUMAN CELL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; SECOND MESSENGER;

ANTIGENS, CD13; CALCIUM; CHEMOTAXIS; EXOCYTOSIS; HUMANS; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEPRILYSIN; NEUTROPHIL ACTIVATION; NEUTROPHILS; OLIGOPEPTIDES; PROTEASE INHIBITORS; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PEPTIDE; SUPEROXIDES;

EID: 0030846767     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00221-9     Document Type: Article

References (30)

1. Hughes J, Smith TW, Kosterlitz HW, Fortergill LA, Morgan BA and Morris HR, Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258: 577-580, 1975.
2. Noble F, Soleihac JM, Soroca-Lucas E, Turcaud S, Fournie-Zaluski MC and Roques BP, Inhibition of the enkephalinmetabolizing enzymes by the first systemically active mixed inhibitor prodrug RB101 induces potent analgesic responses in mice and rats. J Pharmacol Exp Ther 261: 181-190, 1992.
3. Dickenson AH, Enkephalins. A new approach to pain relief? Nature 320: 681-682, 1986.
4. Waksman G, Bouboutou R, Devin J, Bourgoin S, Cesselin F, Hamon M, Fournie-Zaluski MC and Roques B, In vivo and in vitro effects of kelatorphan on enkephalin metabolism in rodent brain. Eur J Pharmacol 117: 233-243, 1985.
5. Nishimura K and Hazato T, Isolation and identification of an endogenous inhibitor of enkephalin-degrading enzymes from bovine spinal cord. Biochem Biophys Res Commun 194: 713-719, 1993.
6. Nishimura K and Hazato T, Spinorphin, a new inhibitor of enkephalin-degrading enzymes derived from the bovine spinal cord. Jpn J Anesthesiol 42: 1497-1503, 1992.
7. Nishimura K, Ueki M, Kaneto H and Hazato T, Study of a new endogenous inhibitor of enkephalin-degrading enzymes; Pharmacological function and metabolism of Spinorphin. Jpn J Anesthesiol 42: 1663-1670, 1993.
8. Skidgel RA, Jackman HL and Erdos EG, Metabolism of substance P and bradykinin by human neutrophils. Biochem Pharmacol 41: 1335-1344, 1991.
9. Iwamoto I, Kimura A, Yamazaki H, Nakagawa N, Tomioka H and Yoshida S, Neutral endopeptidase modulates substance P-induced activation of human neutrophils. Int Arch Allergy Appl Immunol 93: 133-138, 1990.
10. Shipp MA and Look AT, Hematopoietic differentiation antigens that are membrane-associated enzymes: Cutting is the key. Blood 82: 1052-1070, 1993.
11. Shipp MA, Stefano GB, D'Adamio L, Switzer SN, Howard FD, Sinisterra J, Scharrer B and Reinherz EL, Downregulation of enkephalin-mediated inflammatory responses by CD10/ neutral endopeptidase 24-11. Nature 347: 394-396, 1990.
12. Shipp MA, Stefano GB, Switzer SN, Griffin JD and Reinherz EL, CD10(CALLA)/neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration, and adhesion proteins, and is itself regulated by neutrophil activation. Blood 78: 1834-1841, 1991.
13. Kanayama N, Kajiwara Y, Goto J, el Maradny E, Maehara K, Andou K and Terao T, Inactivation of interleukin-8 by aminopeptidase N (CD13). J Leukoc Biol 57: 129-134, 1995.
14. Christiansen NO, Pertussis toxin inhibits the fMLP-induced membrane association protein kinase C in human neutrophils. J Leukoc Biol 47: 60-63, 1990.
15. Liang S, Woodlock TJ, Whitin JC, Lichtman MA and Segal GB, Signal transduction in N-formylmethionyl-leucyl-phenylalanine and concanavalin A stimulated neutrophils: Superoxide production without a rise in intracellular free calcium. J Cell Physiol 145: 295-302, 1990.
16. Williams LT, Snyderman R, Pike MC and Lefkowitz RJ, Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. Proc Natl Acad Sci USA 74: 1204-1208, 1977.
17. Elferink JGR and de Koster BM, Ryanodine as inhibitor of chemotactic peptide-induced chemotaxis in human neutrophils. Biochem Pharmacol 50: 975-979, 1995.
18. Böyum A, A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. General sedimentation properties of white blood cells in a l g gravity field. Scan J Clin Lab Invest (Suppl 97) 21: 51-76, 1968.
19. Yamamoto Y, Yamaguchi T, Shimamura M and Hazato T, Angiotensin III is a new chemoattractant for polymorphonuclear leukocytes. Biochem Biophys Res Commun 193: 1038-1043, 1993.
20. Babior BM, Kipnes RS and Curnutte JT, Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 52: 741-744, 1973.
21. Yamamoto Y, Yamaguchi T, Sato K, Nuhikawa Y and Hiragun A, SGP140: Identification of a novel component on human polymorphonuclear leukocyte cell surface involved in chemotactic and phagocytic activities. Exp Hematol 16: 12-20, 1988.
22. Mallya SK and Van Wart HE, Mechanism of inhibition of human neutrophil collagenase by gold(I) crysotherapeutic compound. Interaction at a heavy metal binding site. J Biol Chem 264: 1594-1601, 1989.
23. Iwamoto I, Kimura A, Ochiai K, Tomioka H and Yoshida S, Distribution of neutral endopeptidase activity in human blood leukocytes. J Leukoc Biol 49: 116-125, 1991.
24. Ashmun RA and Look AT, Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells. Blood 75: 462-469, 1990.
25. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985.
26. Cirino G, Cicala C, Sorrentino L, Ciliberto G, Arpaia G, Perretti M and Flower RJ, Anti-inflammatory actions of an N-terminal peptide from human lipocortin 1. Br J Pharmacol 108: 573-574, 1993.
27. Trotz ME and Said SI, Vasoactive intestinal peptide and helodermin inhibit phospholipase A2 activity in vitro. Regul. Pept 48: 301-307, 1993.
28. Doherty NS and Janusz MJ, Neutrophil proteases: Their physiological and pathological roles. In: Immunopharmacology of Neutrophils (Eds. Hellewell PG and Williams TJ), pp. 55-94. Academic Press, San Diego, 1994.
29. Aswanikumar S, Corcoran B, Shiffman E, Day AR, Freer RJ, Showell HJ and Becker EL, Demonstration of a receptor on rabbit neutrophils for chemotactic peptides. Biochem Biophys Res Commun 74: 810-817, 1977.
30. Chenoweth DE and Hugh TE, Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. Proc Natl Acad Sci USA 75: 3943-3947, 1978.